![Glenn Sblendorio](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Sblendorio
Président chez
MINERALYS THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Glenn P.
Sblendorio is currently President & Chief Executive Officer at Ophthotech Corp.
(New Jersey), Chairman at Mineralys Therapeutics, Inc., Chairman at Nanoscope Therapeutics, Inc., and Director at 4D Molecular Therapeutics, Inc. Former roles include Chief Executive Officer & Managing Director at Mpm Capital Advisors LLC from 1998 to 2000, Chief Executive Officer & Director at IVERIC bio, Inc. from 2021 to 2023, Chairman at NuLens Ltd., President, CFO, Treasurer & Director at The Medicines Co. from 2013 to 2016, Independent Director at Intercept Pharmaceuticals, Inc. from 2014 to 2023, Independent Director at Amicus Therapeutics, Inc. from 2006 to 2026, Managing Director at Sony Interactive Entertainment LLC from 1992 to 1996, Head-Finance & Controller at Amgen, Inc., Chief Financial Officer & Executive Vice President at Oldtech, Inc. from 2002 to 2005, Chief Financial Officer at Hoffmann-La Roche, Inc., Chief Financial Officer & Vice President-Finance at Roche Molecular Systems, Inc. from 1992 to 1993, and Chief Financial Officer at Millennium Venture Management LLC.
Education includes an MBA from Fairleigh Dickinson University conferred in 1985 and an undergraduate degree from Pace University conferred in 1978.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Glenn Sblendorio
| Sociétés | Poste | Début |
|---|---|---|
| MINERALYS THERAPEUTICS, INC. | Président | - |
| 4D MOLECULAR THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/01/2026 |
Ophthotech Corp. (New Jersey)
 Ophthotech Corp. (New Jersey) Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for eye diseases | Directeur Général | - |
Nanoscope Therapeutics, Inc.
 Nanoscope Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Président | - |
Anciens postes connus de Glenn Sblendorio
| Sociétés | Poste | Fin |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Directeur/Membre du Conseil | 27/04/2026 |
| INTERCEPT PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 08/11/2023 |
| IVERIC BIO, INC. | Directeur Général | 11/07/2023 |
| THE MEDICINES COMPANY | Directeur Financier/CFO | 01/03/2016 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Directeur Financier/CFO | 01/11/2005 |
Formation de Glenn Sblendorio
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
18
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 18 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
Intercept Pharmaceuticals, Inc.
 Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases | Health Technology |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Fairleigh Dickinson University
 Fairleigh Dickinson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pace University
 Pace University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
NuLens Ltd.
 NuLens Ltd. Electronic ComponentsElectronic Technology Develops and markets intraocular lens technology | Electronic Technology |
Roche Molecular Systems, Inc.
 Roche Molecular Systems, Inc. Medical/Nursing ServicesHealth Services Develops & produces molecular-based diagnostic tests & automated testing platforms | Health Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. BiotechnologyHealth Technology Operates as a science-driven biopharmaceutical company that develops novel treatments for retinal diseases | Health Technology |
Sony Interactive Entertainment LLC
 Sony Interactive Entertainment LLC Packaged SoftwareTechnology Services Develops and sells games hardware & software | Technology Services |
Millennium Venture Management LLC | |
4D Molecular Therapeutics, Inc.
 4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Mpm Capital Advisors LLC | |
Ophthotech Corp. (New Jersey)
Ophthotech Corp. (New Jersey) Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for eye diseases | Health Technology |
Nanoscope Therapeutics, Inc.
Nanoscope Therapeutics, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Mineralys Therapeutics, Inc.
 Mineralys Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which develops medicines to target diseases | Health Technology |
